Mindray
Mindray Medical International Limited, commonly known as Mindray, is a leading global provider of medical devices and solutions, headquartered in Shenzhen, China (CN). Founded in 1991, the company has established a strong presence in key operational regions, including North America, Europe, and Asia, making significant strides in the healthcare industry. Specialising in innovative medical technologies, Mindray focuses on areas such as patient monitoring, in-vitro diagnostics, and ultrasound imaging. Its core products are distinguished by their advanced features and user-friendly designs, catering to the diverse needs of healthcare professionals. With a commitment to quality and innovation, Mindray has achieved notable milestones, including numerous industry awards and recognitions, solidifying its position as a trusted partner in healthcare worldwide.
DitchCarbon Score
How does Mindray's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mindray's score of 29 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mindray's reported carbon emissions
In 2023, Mindray, headquartered in China (CN), reported total carbon emissions of approximately 72,075,560 kg CO2e for Scope 1 and about 67,978,550 kg CO2e for Scope 2, resulting in a combined total of around 75,186,110 kg CO2e. In the UK, Mindray disclosed Scope 2 emissions of about 25,700 kg CO2e and Scope 3 emissions of approximately 2,769,470 kg CO2e, which includes significant contributions from upstream transportation and distribution (about 2,185,770 kg CO2e) and employee commuting (approximately 224,040 kg CO2e). Mindray has set ambitious climate commitments, aiming for a 25% reduction in greenhouse gas (GHG) intensity for both Scope 1 and Scope 2 emissions by 2030, using 2021 as the baseline year. This target reflects the company's proactive approach to mitigating its carbon footprint and aligns with industry standards for climate action. The emissions data reported by Mindray is cascaded from its parent company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., ensuring consistency and transparency in its environmental reporting. As the company continues to enhance its sustainability initiatives, it remains focused on reducing its overall carbon emissions and improving energy efficiency across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 0,000,000 |
| Scope 2 | - | - | - | - | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mindray is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
